Interleukin-1β Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-β1
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
One of the most potent pro-fibrotic cytokines is transforming growth factor (TGFβ). TGFβ is involved in the activation of fibroblasts into myofibroblasts, resulting in the hallmark of fibrosis: the pathological accumulation of collagen. Interleukin-1β (IL1β) can influence the severity of fibrosis, however much less is known about the direct effects on fibroblasts. Using lung and dermal fibroblasts, we have investigated the effects of IL1β, TGFβ1, and IL1β in combination with TGFβ1 on myofibroblast formation, collagen synthesis and collagen modification (including prolyl hydroxylase, lysyl hydroxylase and lysyl oxidase), and matrix metalloproteinases (MMPs). We found that IL1β alone has no obvious pro-fibrotic effect on fibroblasts. However, IL1β is able to inhibit the TGFβ1-induced myofibroblast formation as well as collagen synthesis. Glioma-associated oncogene homolog 1 (GLI1), the Hedgehog transcription factor that is involved in the transformation of fibroblasts into myofibroblasts is upregulated by TGFβ1. The addition of IL1β reduced the expression of GLI1 and thereby also indirectly inhibits myofibroblast formation. Other potentially anti-fibrotic effects of IL1β that were observed are the increased levels of MMP1, -2, -9 and -14 produced by fibroblasts exposed to TGFβ1/IL1β in comparison with fibroblasts exposed to TGFβ1 alone. In addition, IL1β decreased the TGFβ1-induced upregulation of lysyl oxidase, an enzyme involved in collagen cross-linking. Furthermore, we found that lung and dermal fibroblasts do not always behave identically towards IL1β. Suppression of COL1A1 by IL1β in the presence of TGFβ1 is more pronounced in lung fibroblasts compared to dermal fibroblasts, whereas a higher upregulation of MMP1 is seen in dermal fibroblasts. The role of IL1β in fibrosis should be reconsidered, and the differences in phenotypical properties of fibroblasts derived from different organs should be taken into account in future anti-fibrotic treatment regimes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interleukin 1 can not only induce, but also inhibit, collagen production, proliferation and myofibroblasts formation in dermal and lung fibroblasts by inhibition of TGFβ signaling (103, 104).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [104]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 1×
“One of the key processes in fibrosis is the activation of fibroblasts into myofibroblasts [13], a”
BackgroundTransforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundDiversity, topographic differentiation, and positional memory in human fibroblasts
Chang, H. Y., Chi, J.-T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162488599 · Cited by 1,151 · cited 2×
“This difference in behaviour between dermal and lung fibroblasts is in line with the observation (albeit widely neglected) that fibroblasts derived from different organs show major differences in phenotypic properties, as reflected by huge differences in gene expression patterns [37,38].”
BackgroundResultSime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050 · cited 1×
“are characterized by the presence of cytoplasmic stress fibers and show an excessive production of collagen [9,15,16,17,18,19,20].”
BackgroundBroekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753 · cited 2×
“Like various organ fibrosis, lung and skin fibrosis are mediated by the IL1b [6,7,8].”
BackgroundBleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730 · cited 2×
“Like various organ fibrosis, lung and skin fibrosis are mediated by the IL1b [6,7,8].”
BackgroundSiwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
Cited by
Regeneration of Dermis: Scarring and Cells Involved
Rippa, A. L., Kalabusheva, E. P., & Vorotelyak, E. A. (2019) · Cells · doi:10.3390/cells8060607 · Cited by 294
“The search for antifibrotic factors has shown that TGF-β3 suppresses scar formation [164,165]; bFGF (FGF-2) [166–169] and IL-1β [170,171] are suppressors of α-SMA expression and mFB generation, antagonizing the effect of TGF-β1.”
BackgroundOrigin and Consequences of Necroinflammation
Sarhan, M., Land, W. G., Tonnus, W., Hugo, C. P., & Linkermann, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00041.2016 · Cited by 207
Current and upcoming therapies to modulate skin scarring and fibrosis
Coentro, J. Q., Pugliese, E., Hanley, G., Raghunath, M., & Zeugolis, D. I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.009 · Cited by 204
Molecular and tissue alterations of collagens in fibrosis
Ricard-Blum, S., Baffet, G., & Théret, N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.004 · Cited by 173
“synthesis in dermal and lung fibroblasts [74].”
Hodges, P. W., James, G., Blomster, L. V., Hall, L., Schmid, A. B., Shu, C. C., Little, C. B., & Melrose, J. (2015) · Spine · doi:10.1097/brs.0000000000000972 · Cited by 162
Metadata
- Authors
- Mia, M. M., Boersema, M., & Bank, R. A.
- Affiliations
- University Medical Center Groningen (NL)
- Corresponding author
- Bank, Ruud A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-12
- Volume
- 9
- Issue
- 3
- Pages
- e91559
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3951452
- OpenAlex
- W2155540606
- Cited by
- 109
- References
- 76
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 14 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 11 · 2019: 13 · 2018: 11 · 2017: 9 · 2016: 5 · 2015: 13 · 2014: 2
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- National University of Singapore (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Funders
- ZonMw (40-00506-98-9021)
- Universitair Medisch Centrum Groningen (40-00506-98-9021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- IL-1β, TGF-β1, myofibroblast differentiation, fibroblast activation, fibrosis, extracellular matrix synthesis, collagen synthesis, Gli1, Hedgehog signaling, matrix metalloproteinases, lysyl oxidase, collagen cross-linking, dermal fibroblasts, lung fibroblasts, COL1A1
- MeSH terms
- Zinc Finger Protein GLI1, Cell Differentiation, Dose-Response Relationship, Drug, Drug Interactions, Extracellular Matrix, Fibroblasts, Humans, Lung, Skin, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Enzymologic, Matrix Metalloproteinases, Collagen Type I, Collagen Type III, Interleukin-1beta, Transforming Growth Factor beta1, Hedgehog Proteins, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin-1β Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-β1. https://app.cochat.ai/papers/10.1371/journal.pone.0091559
- The paper
- Mia, M. M., Boersema, M., & Bank, R. A. (2014). Interleukin-1β Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-β1. PLoS ONE. https://doi.org/10.1371/journal.pone.0091559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.